The WGND membership rests with individuals, not institutions. Thus, the WGND has no "lead agency" and is not dominated by any institution or group of institutions. The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers. Members represent the private and public sectors and come from diverse geographical locations.
Membership is based on the following basic criteria:
The two prime qualifications for membership are:
(i) a shared understanding of the mission and goals of the WGND;
(ii) the ability to engage in activities to achieve those goals, playing an advisory role and/or executing projects;
Members are expected to attend an annual meeting, either in person or by teleconference for those without access to travel support;
Members of the WGND employed by large institutions are expected to support Secretariat and WGND activities through financial or staff support, and by hosting meetings of the WGND, Core Group (CG), or ad hoc/subgroups;
Specific individuals may be invited to participate in meetings based on their potential contribution to the activities of the WGND.